NASDAQ:BIOL BIOLASE (BIOL) Stock Price, News & Analysis $0.08 +0.01 (+14.71%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.07▼$0.0850-Day Range$0.05▼$0.1952-Week Range$0.04▼$9.35Volume64,423 shsAverage Volume3.36 million shsMarket Capitalization$2.85 millionP/E RatioN/ADividend YieldN/APrice Target$0.40 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get BIOLASE alerts: Email Address BIOLASE MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside412.8% Upside$0.40 Price TargetShort InterestHealthy6.14% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.09 out of 5 stars 3.3 Analyst's Opinion Consensus RatingBIOLASE has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageBIOLASE has only been the subject of 2 research reports in the past 90 days.Read more about BIOLASE's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted6.14% of the float of BIOLASE has been sold short.Short Interest Ratio / Days to CoverBIOLASE has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in BIOLASE has recently decreased by 6.19%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldBIOLASE does not currently pay a dividend.Dividend GrowthBIOLASE does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for BIOL. Previous Next 1.1 News and Social Media Coverage News SentimentBIOLASE has a news sentiment score of 0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for BIOLASE this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for BIOL on MarketBeat in the last 30 days. This is a decrease of -83% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added BIOLASE to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, BIOLASE insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.27% of the stock of BIOLASE is held by insiders.Percentage Held by InstitutionsOnly 8.79% of the stock of BIOLASE is held by institutions.Read more about BIOLASE's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of BIOLASE is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BIOLASE is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about BIOLASE's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…Check out the new "Crypto Bull Run Millionaire Blueprint" now! About BIOLASE Stock (NASDAQ:BIOL)BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.Read More BIOL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BIOL Stock News HeadlinesJuly 24 at 11:51 AM | americanbankingnews.comBIOLASE (NASDAQ:BIOL) Now Covered by Analysts at StockNews.comJuly 19, 2024 | msn.comCosmetic dentistry gets more bite: Five emerging trendsJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.May 14, 2024 | markets.businessinsider.comWhat Wall Street expects from Biolase's earningsMay 14, 2024 | msn.comBIOLASE, Inc. (NASDAQ:BIOL) Q1 2024 Earnings Call TranscriptMay 14, 2024 | finance.yahoo.comQ1 2024 BIOLASE Inc Earnings CallMay 14, 2024 | finance.yahoo.comBiolase Inc (BIOL) Q1 2024 Earnings Call Transcript Highlights: Strategic Gains Amidst Economic ...May 12, 2024 | msn.comBiolase Q1 2024 Earnings PreviewJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.May 1, 2024 | au.finance.yahoo.comBIOLASE, Inc. (BIOL) stock historical prices & data – Yahoo FinanceApril 26, 2024 | markets.businessinsider.comMama’s Creations: Strong Financial Performance and Growth Potential Justify Buy RatingApril 17, 2024 | msn.comBIOLASE (BIOL) Price Target Decreased by 19.68% to 11.45March 29, 2024 | markets.businessinsider.comCelsius Holdings: Strong Buy on Robust Finances and Global Expansion StrategyMarch 24, 2024 | marketwatch.comBiolase Shares Jump 27% After Upbeat 2024 Revenue GuidanceMarch 23, 2024 | seekingalpha.comBIOLASE, Inc. (BIOL) Q4 2023 Earnings Call TranscriptMarch 23, 2024 | markets.businessinsider.comBiolase’s Strong Q4 Performance and Positive 2024 Outlook Affirm Buy RatingMarch 23, 2024 | finance.yahoo.comBIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call TranscriptMarch 22, 2024 | markets.businessinsider.comWhy BIOLASE Shares Are Surging FridaySee More Headlines Receive BIOL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BIOLASE and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/13/2024Today7/27/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Dental equipment & supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:BIOL Previous SymbolNASDAQ:BLTI CUSIPN/A CIK811240 Webwww.biolase.com Phone(949) 361-1200Fax949-273-6677Employees160Year FoundedN/APrice Target and Rating Average Stock Price Target$0.40 High Stock Price Target$0.40 Low Stock Price Target$0.40 Potential Upside/Downside+412.8%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($14.94) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-20,630,000.00 Net Margins-43.56% Pretax Margin-43.46% Return on Equity-1,782.73% Return on Assets-57.55% Debt Debt-to-Equity RatioN/A Current Ratio1.17 Quick Ratio0.64 Sales & Book Value Annual Sales$49.16 million Price / Sales0.06 Cash FlowN/A Price / Cash FlowN/A Book Value($0.07) per share Price / Book-1.11Miscellaneous Outstanding Shares36,600,000Free Float33,317,000Market Cap$2.85 million OptionableNot Optionable Beta0.71 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Key ExecutivesMr. John R. Beaver (Age 63)President, CEO & Director Comp: $377.53kMs. Jennifer Bright (Age 52)Chief Financial Officer Comp: $355.98kMr. Steven Sandor (Age 43)Chief Operating Officer Comp: $336.39kMr. Michael C. Carroll (Age 52)Corporate Secretary Key CompetitorsBiomericaNASDAQ:BMRAPAVmedNASDAQ:PAVMGlucoTrackNASDAQ:GCTKSonendoNYSE:SONXIntelligent Bio SolutionsNASDAQ:INBSView All CompetitorsInstitutional OwnershipVirtu Financial LLCBought 131,248 shares on 5/20/2024Ownership: 0.430%View All Institutional Transactions BIOL Stock Analysis - Frequently Asked Questions How have BIOL shares performed this year? BIOLASE's stock was trading at $1.1220 at the beginning of 2024. Since then, BIOL shares have decreased by 93.0% and is now trading at $0.0780. View the best growth stocks for 2024 here. How were BIOLASE's earnings last quarter? BIOLASE, Inc. (NASDAQ:BIOL) released its quarterly earnings results on Monday, May, 13th. The medical technology company reported ($0.36) earnings per share for the quarter. The medical technology company had revenue of $10.13 million for the quarter. BIOLASE had a negative trailing twelve-month return on equity of 1,782.73% and a negative net margin of 43.56%. When did BIOLASE's stock split? BIOLASE shares reverse split on Friday, July 28th 2023. The 1-100 reverse split was announced on Friday, July 28th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. What is John R. Beaver's approval rating as BIOLASE's CEO? 4 employees have rated BIOLASE Chief Executive Officer John R. Beaver on Glassdoor.com. John R. Beaver has an approval rating of 13% among the company's employees. This puts John R. Beaver in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 35.0% of employees surveyed would recommend working at BIOLASE to a friend. How do I buy shares of BIOLASE? Shares of BIOL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of BIOLASE own? Based on aggregate information from My MarketBeat watchlists, some other companies that BIOLASE investors own include Himax Technologies (HIMX), Accelerate Diagnostics (AXDX), Biocept (BIOC), Magnachip Semiconductor (MX), Fluidigm (FLDM), Matinas BioPharma (MTNB) and MicroVision (MVIS). This page (NASDAQ:BIOL) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIOLASE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BIOLASE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIOL Stock Alerts